The service, designed for companies that prioritize the promotion of the health and well-being of their employees, is backed by the extensive experience of the Atrys Genetics Laboratory, equipped with...
Read moreEl estudio observacional internacional de pacientes con Colangiocarcinoma (CCA) más exhaustivo realizado hasta la fecha en Latinoamérica, coordinado por personal investigador del Instituto de Invest...
Read moreLas anemias congénitas, un grupo de trastornos sanguíneos caracterizados por la incapacidad del cuerpo para producir glóbulos rojos sanos de manera eficiente, condicionan la vida de quienes las pad...
Read moreAunque hoy la implicación de este virus que infecta a la mayor parte de la población se considera una condición necesaria para padecer la enfermedad, aún no se sabe por qué solo la desarrolla un ...
Read moreA study from IRB Barcelona, funded by Fundación CRIS contra el cáncer, demonstrates that the “previous state” of blood stem cells plays a decisive role in the subtype of leukaemia that develops....
Read moreEl estudio, publicado en la European Journal of Pharmaceutical Sciences, propone el uso de un hidrogel biodegradable que se coloca en la cavidad dejada por el tumor tras la cirugía. Este material lib...
Read moreAt ABYLABEL, they are commited to excellence and social responsability. This is why they are proud to present their AbyPanels, a tool that saves time and modey in the development of antibodies for res...
Read moreEl estudio identifica nuevas vulnerabilidades en el microambiente tumoral del linfoma B difuso de células grandes
Read moreTreatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common. An international team has now test in animal models a new "promising therape...
Read morePuesto en marcha el primer ensayo clínico para pacientes con linfoma refractario, que se basa en un vector no viral desarrollado en España
Read moreThe results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.
Read moreThe study has shown that Pevonedistat, a drug that blocks protein degradation, enhances the effect of Laduviglusib, an inhibitor previously shown to induce the death of leukaemic B lymphocytes. The co...
Read more